second-generation tau oligomer inihibitors (Oligomerix)

N/A

Report date: 2025/03/20 09:16:48
NME

Base Information

Drug Namesecond-generation tau oligomer inihibitors (Oligomerix)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsNerve DegenerationDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOligomerix Inc
China Registration ClassN/A

Develop Information

Active CompaniesOligomerix Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A